Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

706
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
706
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

1.3K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

977
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
977
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

1.2K
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observer bias in medical evaluations: a critical pre-analytical factor impacting the quality of judicial evidence in forensic-toxicological casework.

International journal of legal medicine·2026
Same author

Cochrane Evaluation of (Semi-) Automated Review Methods (CESAR): Protocol for an adaptive platform study within reviews.

Journal of clinical epidemiology·2026
Same author

Impact of moderate alcohol consumption on visuo-motor skills in neurosurgical residents.

Scientific reports·2026
Same author

Direct alcohol biomarkers in blood samples of traffic offenders - correlation between blood alcohol concentration, ethyl glucuronide, and phosphatidylethanol.

International journal of legal medicine·2026
Same author

Gastric emptying times of high-fat, high-carbohydrate and high-protein standard meals using MRI examinations - a contribution to estimating the time since death.

International journal of legal medicine·2026
Same author

Operation Stork Speed represents an opportunity to reform infant formula clinical trials.

Nature food·2026
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.2K

Perazine for schizophrenia.

Stefan Leucht1, Bartosz Helfer, Benno Hartung

  • 1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Ismaningerstrasse 22, München, Germany, 81675.

The Cochrane Database of Systematic Reviews
|January 16, 2014
PubMed
Summary
This summary is machine-generated.

Limited trials suggest perazine may be effective for schizophrenia, but more research is needed. While not causing more general adverse events than placebo, it may increase the need for antiparkinson medication.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.2K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

6.4K

Related Experiment Videos

Last Updated: May 4, 2026

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.2K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.2K
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

6.4K

Area of Science:

  • Psychiatry and Psychopharmacology
  • Clinical Trials and Evidence Synthesis

Background:

  • Perazine, a phenothiazine derivative, is used for schizophrenia treatment, particularly in certain European countries.
  • It is reputed to have a lower incidence of extrapyramidal adverse effects compared to other antipsychotics.

Purpose of the Study:

  • To evaluate the efficacy and safety of perazine in patients with schizophrenia or related psychoses.
  • To compare perazine against placebo, no treatment, and other antipsychotic medications.

Main Methods:

  • A systematic search of multiple databases (e.g., Cochrane Schizophrenia Group Trials Register, MEDLINE, EMBASE) was conducted.
  • Randomized controlled trials (RCTs) comparing perazine with other interventions were selected.
  • Data extraction and risk of bias assessment were performed independently by review authors; meta-analysis was conducted where possible.

Main Results:

  • Seven trials involving 479 participants were included. One trial suggested perazine superior to trimipramine for global improvement, but evidence quality was low.
  • Perazine did not increase general adverse events compared to placebo but was associated with a higher need for antiparkinson medication.
  • Limited data from six small trials comparing perazine with other antipsychotics (e.g., amisulpride, haloperidol) showed no significant differences in study withdrawal or specific extrapyramidal side effects like akathisia or parkinsonism.

Conclusions:

  • The current body of evidence from randomized controlled trials on perazine is insufficient to draw firm conclusions regarding its efficacy and safety.
  • While perazine might have a similar risk of extrapyramidal side effects as some second-generation antipsychotics, this requires confirmation in larger, well-designed studies.
  • Further high-quality research is necessary to clarify the therapeutic profile of perazine in schizophrenia treatment.